Moreover, GSDMB modulated the glycolysis by up-regulating the expression of HK2 in bladder cancer cells (Fig. 2E-2L), suggesting that GSDMB might be involved in regulating the glucose metabolism of bladder cancer cells through STAT3-related signaling pathways. Here, STAT3 is linked to urinary bladder carcinoma.